CNTG Chart
- 52-Week Range: $3.15 - $11.72
- Market Capitalization: $91.28M
- Short Percentage: 0%
- Target Price: $13.88
- Shares Outstanding: 27.07M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- 4D pharma conference poster underlines safety and potential efficacy of asthma drug candidateProactive Investors | May 17th
- FDA and Abbott Nutrition reach deal to restart production of baby formula amid nationwide shortageBusiness Insider | May 16th
- Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 16th
- Celcuity Inc. (CELC) CEO Brian Sullivan on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 16th
- Miromatrix Medical Inc. (MIRO) CEO Jeff Ross on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 16th
We searched over 50 sources and couldn't find any news or press releases related to Centogene N.V.
Here are some articles we think you might like.
Company Info
Website: https://www.centogene.com
Address: Am Strande 7, Rostock, Germany, 18055
Sector: Healthcare
Industry: Diagnostics & Research
Full time employees: 808
Address: Am Strande 7, Rostock, Germany, 18055
Sector: Healthcare
Industry: Diagnostics & Research
Full time employees: 808
$CNTG buy the dip were blasting off
$CNTG buy buy buy!!
$CNTG has just been halted from trading due to volatility.
$CNTG Monday will be very interesting.
$CNTG volume is almost nonexistent
$CNTG going green
$CNTG looking good today??
$CNTG I would not be a bear now
$CNTG upupup!
$CNTG let’s gooooo